Dr. Priti Mehta

• Recipient of the SIOP Scholarship (2004) – International Society of Paediatric Oncology.
• Best Poster Award – Thalassemia International Federation (2008).
• Lifetime Member – IAP-PHO Chapter, India.
• Member – European Society for Blood and Marrow Transplantation (EBMT).

Published research papers

• Advanced Cellular Therapies in Paediatric Leukemia – Journal of Paediatric Haematology (2022)
• Outcomes of BMT in Thalassemia Major – Indian Journal of Pediatrics (2019)
• CAR T-cell Therapy: A New Era for Pediatric Oncology – International Oncology Review (2021)

Ongoing or past clinical trial participation

• Participation in multi-centre trials for Chimeric Antigen Receptor Therapy.
• Clinical research on transplant outcomes for primary immunodeficiency diseases.

Successful BMT for Thalassemia Major

• A young child suffering from Thalassemia Major required frequent blood transfusions, impacting their growth. Dr. Priti Mehta performed a successful matched sibling Bone Marrow Transplant. The child is now transfusion-free and leading a healthy, active life. Families often praise her "thorough" approach and "reassuring" guidance throughout the transplant process.

CAR T-cell Therapy for Relapsed Leukemia

• In a challenging case of relapsed Acute Lymphoblastic Leukemia where standard treatments failed, Dr. Priti Mehta utilized advanced CAR T-cell therapy. The patient achieved complete remission. The parents noted her expertise in advanced cellular therapies and her ability to provide "hope in the most difficult times."

BMT for Primary Immunodeficiency

• Infants with severe immunodeficiency disorders face life-threatening infections. Dr. Priti Mehta has successfully managed several such cases with curative transplants. Testimonials highlight her "meticulous pre-operative planning" and the specialized post-operative care that ensured a "smooth and safe recovery."

• Patient-Centred Care: Dr. Priti Mehta believes in a holistic approach to paediatric cancer care. She ensures that treatment plans are not only evidence-based but also tailored to the emotional and developmental needs of the child. Her communication style is transparent, helping parents make informed decisions with confidence.
• Technology & Innovation: She actively integrates the latest global innovations, such as CAR T-cell therapy and advanced biologicals, into her practice. By combining UK-trained expertise with state-of-the-art technology, Dr. Mehta strives to offer curative options for even the most complex haematological disorders.

Treatments performed by Dr. Priti Mehta, Paediatric Haematologist-Oncologist:

Note: For consultation fee or personalised cost estimate, you can connect with the Cancer Rounds team.

Cancer Rounds provides specialized support for families traveling for treatment:

• Language support: Cancer Rounds offers multilingual assistance to ensure clear communication between the medical team and the family.
• Visa and travel assistance: Comprehensive help with medical visas and local stay arrangements is provided by the Cancer Rounds international desk.
• Pre-treatment virtual consultations: Families can access Cancer Rounds to schedule video calls with the doctor for a preliminary review of medical records before traveling.